Drugs from nature targeting inflammation (DNTI): A successful Austrian interdisciplinary network project

9Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

© 2016 The Author(s).Inflammation is part of numerous pathological conditions, which are lacking satisfying treatment and effective concepts of prevention. A national research network project, DNTI, involving scientists from six Austrian universities as well as several external partners aimed to identify and characterize natural products capable of combating inflammatory processes specifically in the cardiovascular system. The combined use of computational techniques with traditional knowledge, high-tech chemical analysis and synthesis, and a broad range of in vitro, cell-based, and in vivo pharmacological models led to the identification of a series of promising anti-inflammatory drug lead candidates. Mechanistic studies contributed to a better understanding of their mechanism of action and delivered new knowledge on the molecular level of inflammatory processes. Herein, the used approaches and selected highlights of the results of this interdisciplinary project are presented.

Cite

CITATION STYLE

APA

Waltenberger, B., Atanasov, A. G., Heiss, E. H., Bernhard, D., Rollinger, J. M., Breuss, J. M., … Stuppner, H. (2016, March 1). Drugs from nature targeting inflammation (DNTI): A successful Austrian interdisciplinary network project. Monatshefte Fur Chemie. Springer-Verlag Wien. https://doi.org/10.1007/s00706-015-1653-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free